Phoenix Wealth Advisors Allogene Therapeutics, Inc. Transaction History
Phoenix Wealth Advisors
- $229 Million
- Q4 2024
A detailed history of Phoenix Wealth Advisors transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Phoenix Wealth Advisors holds 16,000 shares of ALLO stock, worth $22,560. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,000
Previous 13,000
23.08%
Holding current value
$22,560
Previous $36,000
5.56%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ALLO
# of Institutions
170Shares Held
132MCall Options Held
59.4KPut Options Held
113K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$26.4 Million1.25% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$23.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$15.3 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$11.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$10.2 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $203M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...